Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

The most popular videos in 2021 included the use of ECMO for COVID-19 patients, a demonstration of the Medis QFR angiography image derived FFR system, and the use of remote EP monitoring systems.
Feature

December 26, 2021 — Here is a list of the most popular videos on the DAIC website from the past year in 2021 based on ...

Home December 26, 2021
Home
Top stories on COVID-19 related to cardiology in 2021.
Feature | Coronavirus (COVID-19)

COVID-19 was the single biggest topic readers came to DAIC for information in 2021, resulting in more than 300,000 ...

Home December 16, 2021
Home
The most popular stories in 2021 included several on impact of COVID-19 on cardiology, the use of the Carmat artificial heart, advances in pulsed field ablation in electrophysiology and the FDA cleanace of the first photon-counting CT scanner.
Feature

Here is a list of the top 25 stories in 2021 on the Diagnostic and Interventional Cardiology (DAIC) website based on ...

Home December 16, 2021
Home
News | Coronavirus (COVID-19)

December 15, 2021 — As COVID-19 variants continue to spread and individuals struggle with lingering effects long after ...

Home December 15, 2021
Home
Videos | Coronavirus (COVID-19)

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the University of Maryland School of Medicine ...

Home December 14, 2021
Home
News | Coronavirus (COVID-19)

December 7, 2021 – Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal ...

Home December 07, 2021
Home
Videos | Coronavirus (COVID-19)

Kate Hanneman, M.D., MPH FRCPC, director of cardiac imaging research JDMI, and the medical imaging site director at ...

Home December 06, 2021
Home
News | Coronavirus (COVID-19)

December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a ...

Home December 01, 2021
Home
News | Coronavirus (COVID-19)

November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...

Home November 23, 2021
Home
News | Coronavirus (COVID-19)

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

Home November 19, 2021
Home
News | Coronavirus (COVID-19)

November 17, 2021 — People in the U.S. who live in socially vulnerable neighborhoods, which includes communities with ...

Home November 17, 2021
Home
News | Coronavirus (COVID-19)

November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots ...

Home November 09, 2021
Home
News | Coronavirus (COVID-19)

November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications ...

Home November 05, 2021
Home
Katherine Fornell, age 5, from suburban Chicago, receives her first dose of the COVID-19 vaccine during the first week it became available in the U.S. The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. This was based on a safety review of more than 3,000 patients receiving the vaccine ages 5-11.
Feature | Coronavirus (COVID-19)

November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID ...

Home November 05, 2021
Home
Subscribe Now